Guangdong Taienkang Pharmaceutical (301263.SZ) plans to issue convertible bonds to raise funds of no more than 870 million yuan.
Tiankang (301263.SZ) announced that it plans to issue convertible corporate bonds to unspecified investors, with a total fundraising amount not exceeding 870 million yuan (including the principal). After deducting issuance expenses, the funds raised will be used for: innovative drug research and development projects, industrialization projects of innovative drugs and high-end topical preparations, Huabai Kaisheng preparation production base project, and the construction project of the first phase of Tiankang's modern traditional Chinese medicine preparation production line in Bozhou.
Guangdong Taienkang Pharmaceutical (301263.SZ) announced that the company plans to issue convertible corporate bonds to unspecified investors, raising a total amount of not more than 870 million yuan (including the principal). After deducting issuance expenses, the funds raised are intended for the following purposes: innovative drug research and development projects, industrialization projects of innovative drugs and high-end topical preparations, production base projects of Hua Bo Kai Sheng preparations, and the construction project of the first phase of the modern Chinese medicine preparation production line in Bozhou, Guangdong Taienkang Pharmaceutical.
Related Articles
US Stock Market Move | Q2 Guidance Weakens, Cloudflare (NET.US) Plunges Nearly 25% After Earnings
LONGCHEER (09611) will distribute a final dividend of HKD 5.7133 per 10 shares on June 18th.
CIRC(01763) subsidiary companies CNNC High-Tech and China Zhongyuan signed the "Thailand Substandard Neutron Dose Laboratory Project Technical Service Contract" with Bond Paul.
US Stock Market Move | Q2 Guidance Weakens, Cloudflare (NET.US) Plunges Nearly 25% After Earnings
LONGCHEER (09611) will distribute a final dividend of HKD 5.7133 per 10 shares on June 18th.
CIRC(01763) subsidiary companies CNNC High-Tech and China Zhongyuan signed the "Thailand Substandard Neutron Dose Laboratory Project Technical Service Contract" with Bond Paul.
